GRIAM(SH:600206) Zheng Quan Zhi Xing·2025-07-08 08:07Core Viewpoint - Company plans to transfer lithium sulfide business assets, including patents, proprietary technology, and equipment, through a public listing due to strategic misalignment and lack of management experience in large-scale chemical production [1][2][6] Summary by Sections Transaction Overview - The transaction involves the transfer of lithium sulfide business assets with a minimum listing price not lower than the assessed value of 109.54 million yuan [2][6] - The assessed value of the assets as of April 30, 2025, is 109.54 million yuan, with a significant increase of 107.58 million yuan compared to the book value, resulting in a growth rate of 5,476.85% [2][5] Asset Details - The assets for transfer include two pending patents valued at 1.0782 million yuan, equipment valued at 1.9665 million yuan, and proprietary technology valued at 106.4978 million yuan [2][3] - The production line for lithium sulfide has been established and is capable of small-scale production [2][3] Valuation and Pricing - The valuation was conducted by Zhonglian Asset Appraisal Group using cost and income methods, ensuring a fair and reasonable pricing strategy [3][6] - The company will set the listing price based on the assessed value, ensuring it is not lower than the valuation [6] Impact on the Company - The transfer of high-value patents and proprietary technology is expected to enhance the company's technological innovation capabilities and financial resources for further investment in core business areas [6][7] - The transaction aligns with the company's strategic development plan and is anticipated to positively influence net profit [3][6]